Apogee Therapeutics Inc (APGE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access APGE Annual Balance Sheets →
Balance sheet data covering Apogee Therapeutics Inc–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent105.57
Marketable Securities, Current SH866.36
Cash & Short-term Investments971.00
Notes Receivable, Current9.59
Prepaid Expense And Other Assets Current23.61
Total Current Assets991.73
Equipment/Property/Plant Net4.82
Long-term investments321.94
Other Assets, Noncurrent17.32
Operating Lease Right Of Use Asset7.71
Total Assets1,335.81
Liabilities
Accounts Payable, Current AC3.08
Accrued Liabilities, Current AC32.07
Other Liabilities, Current2.37
Total Current Liabilities37.51
Total Long-term Debt0.00
Other liabilities, Noncurrent103.70
Operating Lease Liability Current3.14
Total Liabilities141.21
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,918.83
Retained Earnings / Accumulated Deficit-721.72
Accumulated Other Comprehensive Income-2.50
Other Equity-2.50
Common Stockholder's Equity0.00
Non-controlling interests & other1,194.60
Total Stockholder's Equity1,194.60
Liabilities & Stockholder's Equity1,335.81
4 historic quarters locked

Sign in to unlock the full Apogee Therapeutics Inc balance sheet history.

About Apogee Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-341289

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.